Category: 8. Health

  • Türkiye suspends animal trade to fight SAT1 livestock virus

    Türkiye suspends animal trade to fight SAT1 livestock virus

    All animal sales venues across Türkiye have been temporarily suspended as a precautionary measure to help control the spread of foot-and-mouth disease, Agriculture and Forestry Minister Ibrahim Yumaklı announced Tuesday.

    “This decision is solely intended to speed up containment of the outbreak and is a temporary animal health measure,” he said.

    In his statement regarding the outbreak, Yumaklı emphasized that the ministry continuously monitors and combats all diseases threatening animal health throughout the country.

    “In 2024, thanks to our intensive vaccination campaigns and preventive measures against foot-and-mouth disease, we achieved an 80% reduction in cases compared to the previous year. Additional precautions were also taken during and before the Qurban Bayram, also known as Eid al-Adha, to manage animal movements,” he said.

    Yumaklı reported that a new serotype of the disease (SAT1) was recently detected, and an effective vaccine was quickly developed and deployed by the ministry’s related departments. However, an increase in animal movement following the Eid holiday has caused a rise in SAT1 outbreaks, prompting the ministry to intensify vaccination efforts.

    The minister stressed that vaccination alone is not sufficient to contain the disease. “Restricting animal movement is one of the most effective global standard practices in combating such diseases. Scientific assessments show that the risk of transmission is especially high in animal markets where direct contact occurs,” he said. Yumaklı also noted that indirect contact – through livestock traders, middlemen, and village visits – can spread the disease rapidly across regions. He emphasized that restricting animal movement at outbreak sites is crucial for both local and national animal health.

    To support this approach, the minister shared the following updates: “To prevent the spread of foot-and-mouth disease and to ensure effective control, the activities of all animal markets, including livestock markets, live animal exchanges, animal collection and sales centers, fairs, and festivals, have been temporarily suspended. This is a preventive and short-term health measure. Vaccination efforts are continuing rapidly, and once the entire livestock population is vaccinated, the restrictions will be gradually lifted based on close monitoring of the outbreak.”

    Yumaklı also reassured the public that the measures do not pose any threat to national food security, stating: “We do not expect any disruption in the supply of animal-based food products, especially meat and dairy. Our current stock and production infrastructure are sufficient to meet national demand. As the Ministry of Agriculture and Forestry, we are closely monitoring the situation, and our veterinary and field teams are on duty 24/7. In collaboration with all stakeholders, we are committed to eliminating threats to animal and public health.”

    The minister concluded by reminding citizens that foot-and-mouth disease does not affect humans, and there is no risk in consuming red meat. He urged the public to follow official updates and guidance and thanked farmers and citizens for their awareness and cooperation.

    The Daily Sabah Newsletter

    Keep up to date with what’s happening in Turkey,
    it’s region and the world.


    You can unsubscribe at any time. By signing up you are agreeing to our Terms of Use and Privacy Policy.
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Continue Reading

  • A midlife MRI that spots rapid aging and signals disease long before symptoms

    A midlife MRI that spots rapid aging and signals disease long before symptoms

    Any high school reunion is a sharp reminder that some people age more gracefully than others. Some enter their older years still physically spry and mentally sharp. Others start feeling frail or forgetful much earlier in life than expected.

    “The way we age as we get older is quite distinct from how many times we’ve traveled around the sun,” said Ahmad Hariri, professor of psychology and neuroscience at Duke University.

    Now, scientists at Duke, Harvard and the University of Otago in New Zealand have developed a freely available tool that can tell how fast someone is aging, and while they’re still reasonably healthy — by looking at a snapshot of their brain.

    From a single MRI brain scan, the tool can estimate your risk in midlife for chronic diseases that typically emerge decades later. That information could help motivate lifestyle and dietary changes that improve health.

    In older people, the tool can predict whether someone will develop dementia or other age-related diseases years before symptoms appear, when they might have a better shot at slowing the course of disease.

    “What’s really cool about this is that we’ve captured how fast people are aging using data collected in midlife,” Hariri said. “And it’s helping us predict diagnosis of dementia among people who are much older.”

    The results were published July 1 in the journal Nature Aging.

    Finding ways to slow age-related decline is key to helping people live healthier, longer lives. But first “we need to figure out how we can monitor aging in an accurate way,” Hariri said.

    Several algorithms have been developed to measure how well a person is aging. But most of these “aging clocks” rely on data collected from people of different ages at a single point in time, rather than following the same individuals as they grow older, Hariri said.

    “Things that look like faster aging may simply be because of differences in exposure” to things such as leaded gasoline or cigarette smoke that are specific to their generation, Hariri said.

    The challenge, he added, is to come up with a measure of how fast the process is unfolding that isn’t confounded by environmental or historical factors unrelated to aging.

    To do that, the researchers drew on data gathered from some 1,037 people who have been studied since birth as part of the Dunedin Study, named after the New Zealand city where they were born between 1972 and 1973.

    Every few years, Dunedin Study researchers looked for changes in the participants’ blood pressure, body mass index, glucose and cholesterol levels, lung and kidney function and other measures — even gum recession and tooth decay.

    They used the overall pattern of change across these health markers over nearly 20 years to generate a score for how fast each person was aging.

    The new tool, named DunedinPACNI, was trained to estimate this rate of aging score using only information from a single brain MRI scan that was collected from 860 Dunedin Study participants when they were 45 years old.

    Next the researchers used it to analyze brain scans in other datasets from people in the U.K., the U.S., Canada and Latin America.

    Faster aging and higher dementia risk

    Across data sets, they found that people who were aging faster by this measure performed worse on cognitive tests and showed faster shrinkage in the hippocampus, a brain region crucial for memory.

    More soberingly, they were also more likely to experience cognitive decline in later years.

    In one analysis, the researchers examined brain scans from 624 individuals ranging in age from 52 to 89 from a North American study of risk for Alzheimer’s disease.

    Those who the tool deemed to be aging the fastest when they joined the study were 60% more likely to develop dementia in the years that followed. They also started to have memory and thinking problems sooner than those who were aging slower.

    When the team first saw the results, “our jaws just dropped to the floor,” Hariri said.

    Links between body and brain

    The researchers also found that people whose DunedinPACNI scores indicated they were aging faster were more likely to suffer declining health overall, not just in their brain function.

    People with faster aging scores were more frail and more likely to experience age-related health problems such as heart attacks, lung disease or strokes.

    The fastest agers were 18% more likely to be diagnosed with a chronic disease within the next several years compared with people with average aging rates.

    Even more alarming, they were also 40% more likely to die within that timeframe than those who were aging more slowly, the researchers found.

    “The link between aging of the brain and body are pretty compelling,” Hariri said.

    The correlations between aging speed and dementia were just as strong in other demographic and socioeconomic groups than the ones the model was trained on, including a sample of people from Latin America, as well as United Kingdom participants who were low-income or non-White.

    “It seems to be capturing something that is reflected in all brains,” Hariri said.

    The work is important because people worldwide are living longer. In the coming decades, the number of people over age 65 is expected to double, reaching nearly one fourth of the world’s population by 2050.

    “But because we live longer lives, more people are unfortunately going to experience chronic age-related diseases, including dementia,” Hariri said.

    Dementia’s economic burden is already huge. Research suggests that the global cost of Alzheimer’s care, for example, will grow from $1.33 trillion in 2020 to $9.12 trillion in 2050 — comparable or greater than the costs of diseases like lung disease or diabetes that affect more people.

    Effective treatments for Alzheimer’s have proven elusive. Most approved drugs can help manage symptoms but fail to stop or reverse the disease.

    One possible explanation for why drugs haven’t worked so far is they were started too late, when the Alzheimer’s proteins that build up in and around nerve cells have already done too much damage.

    “Drugs can’t resurrect a dying brain,” Hariri said.

    But in the future, the new tool could make it possible to identify people who may be on the way to Alzheimer’s sooner, and evaluate interventions to stop it — before brain damage becomes extensive, and without waiting decades for follow-up.

    In addition to predicting our risk of dementia over time, the new clock will also help scientists better understand why people with certain risk factors, such as poor sleep or mental health conditions, age differently, said first author Ethan Whitman, who is working toward a Ph.D. in clinical psychology with Hariri and study co-authors Terrie Moffitt and Avshalom Caspi, also professors of psychology and neuroscience at Duke.

    More research is needed to advance DunedinPACNI from a research tool to something that has practical applications in healthcare, Whitman added.

    But in the meantime, the team hopes the tool will help researchers with access to brain MRI data measure aging rates in ways that aging clocks based on other biomarkers, such as blood tests, can’t.

    “We really think of it as hopefully being a key new tool in forecasting and predicting risk for diseases, especially Alzheimer’s and related dementias, and also perhaps gaining a better foothold on progression of disease,” Hariri said.

    The authors have filed a patent application for the work. This research was supported by the U.S. National Institute on Aging (R01AG049789, R01AG032282, R01AG073207), the UK Medical Research Council (MR/X021149/1), and the New Zealand Health Research Council (Program Grant 16-604).

    Continue Reading

  • Half of the global population can’t afford healthy food

    A healthy diet costs in global average US$3.68 per day in 2021. This is considerably higher than the average food expenditure in almost all low income countries, where people have to do with a diet dominated by staples and oils, lacking protein and a number of micronutrients. The cost of healthy food is also out of reach for many people living above the World Bank’s extreme poverty line.

    A team of researchers have summarized data of the cost of a global ”Healthy food basket” which is closely aligned to a set of national public dietary guidelines. The healthy food basket is composed of six broad categories of food, starchy crops, oils, vegetables, fruits, legumes, nuts and seeds and animal foods. The researchers selected a small number of the cheapest food items in each category to calculate minimum cost of a healthy diet in the countries of the world. Notably, the healthy food basket has a considerably higher share of fruits and vegetables and a lower share of animal source foods (13% compared to 18%) than the average global consumption.

    It is well established that a healthy diet can be costly. Fruits, vegetables and animal foods are relatively expensive while starchy foods, oils and legumes are much cheaper when calculated in cost per energy unit. Oils give in average almost 20 times more food energy than vegetables. You eat vegetables for dietary variation, taste and micronutrients rather than to get sated. Meat is mostly eaten for protein and fat as well as taste and status. Still, meat gives much cheaper energy than both fruits and vegetables. The cost is also the reason for why poor people, mostly, eat very little greens, fruits and animals foods and a lot of staple foods like grain and root crops (see for instance in Pradhan et al 2013). Oils and other fats were traditionally in very short supply in most parts of the world, and most of the fat was of animal origin. The extreme expansion of vegetable oils, mostly palm oil and soy oil, has now made fat cheaper than starch as an energy source.

    The research is based on market prices and obviously both actual consumption and ”cost” will be different for the considerable part of the global poor that are farmers themselves. But even for them I believe it is clear that the poorest often eat a very starch-based diet, supplemented by purchased vegetable (palm) oil, sugar and salt (obviously there are some poor populations engaged in fisheries, livestock or the collection of wild plants that have a different diet). I worked many years in very poor countries and with poor farmers in East Africa and it was striking how seldom they consumed any quantity of vegetables. Those who did grow them did it mostly for the market, to get very much needed income.

    Smallholder Susan Mkandawire in Zambia cooks maize porridge with some salt, palm oil and pumpkin leaves to her family. She sells most of the vegetables she grows and the few chickens she raises to get much needed cash. Photo: Richard Mulonga

    The World Bank now defines extreme poverty by an income below $3 in PPP US dollars (Purchasing Power Parities) in low-income countries, $4.20 in lower-middle income countries and $8.30 in upper-middle income countries. The actual research is for the situation 2021, before most of the recent food price hikes. At that time, the World Bank poverty limit was $2.15. Realistically, around $1.35 of that could be used for food, which is more than one third of the cost of a healthy diet. The World Bank estimates that a little less than half of the global population live with a daily income below $8.30 in 2025. Considering that the bank increased the poverty line in upper-middle income countries from $6.85 to $8.30 between 2022 and 2025 it seems like a fair estimate that half of the global population can’t afford a healthy diet. This also calls into question of how the poverty lines are defined. Shouldn’t a person above the poverty line be able to eat healthy food?

    The researchers conclude that the so called Eat-Lancet diet is even more costly than the Healthy Diet Basket used in this study. This is due to the fact that the EAT Lancet diet has more categories of food and specify quantities of expensive foods such as nuts and fish. One can really question the relevance of making recommendations such as the Eat-Lancet diet when it is out of reach of most people. The Health Diet Basket would, according to this research cause slightly more greenhouse gas emissions than the Eat Lancet.

    Of course, one can’t draw too far reaching conclusions from this kind of research. In the end food is about a lot more than cost and calories and even if national data has been used, food consumption data is not particularly accurate and even less so in countries with high levels of self-provisioning.

    What constitutes a healthy diet is also vigorously debated and I don’t want to get into details about it here. My own opinion is that a mixed diet based on local foods will be fine, which means bigger variations than in the efforts to prescribe global diets. Where I live in the Sweden it will mean a diet with more animal foods than the global average and less fruit. In almost no countries of the world, people eat as much vegetables as is recommended in dietary recommendations and despite being a passionate vegetable grower since 1977 I am not convinced about the feasibility of increasing vegetable consumption to satisfy nutritional recommendation (Rundgren 2019).

    The research referred to here is not fine grained enough to cover all aspects, as the researchers point out themselves. In many cases the starch component will be refined (or be sugar) and not be whole grain for instance, and fish, various meats and dairy have different nutritional profiles and health reputation.

    In a coming article I will look into to what extent countries can feed their population with a healthy diet.


    References

    Herforth, A.W., Bai, Y., Venkat, A. et al. The Healthy Diet Basket is a valid global standard that highlights lack of access to healthy and sustainable diets. Nat Food 6, 622–631 (2025). https://doi.org/10.1038/s43016-025-01177-0

    Our World in Data 2025, Share in poverty relative to different poverty lines, World, https://ourworldindata.org/grapher/share-in-poverty-relative-to-different-poverty-thresholds

    Pradhan P, Reusser DE, Kropp JP (2013) Embodied Greenhouse Gas Emissions in Diets. PLoS ONE 8(5): e62228. https://doi.org/10.1371/journal.pone.0062228

    Rundgren, G 2019, Five dollars a day is not enough for five a day, Garden Earth https://gardenearth.substack.com/p/five-dollars-is-not-enough-for-five-day

    Rundgren, G 2022, Food and agriculture number crunching, part 3, Garden Earth

    World Bank 2025, Measuring Poverty. https://www.worldbank.org/en/topic/measuringpoverty

    Photo: Richard Mulonga. Author suppliled.

    Continue Reading

  • Can AI spot alzheimer’s before it starts? This new brain-scan got 88% diagnoses right – Healthcare News

    Can AI spot alzheimer’s before it starts? This new brain-scan got 88% diagnoses right – Healthcare News

    A new artificial intelligence (AI) tool is helping doctors better understand and diagnose dementia, including Alzheimer’s disease, a new study has found. The tool, called StateViewer, was created by researchers at the Mayo Clinic. It was able to correctly identify the type of dementia a patient had in 88 per cent of cases, according to findings published in the journal Neurology.

    Doctors say the tool could make it easier to diagnose dementia earlier, even in people who have other medical issues that make it hard to figure out the cause of memory loss or confusion.

    “Every patient who walks into my clinic carries a unique story shaped by the brain’s complexity,” said Dr. David Jones, the study’s senior author and head of the Mayo Clinic’s Neurology AI Program. “StateViewer helps us give clearer answers, earlier.”

    How does it work

    To build the tool, researchers used over 3,600 brain scans called FDG-PET scans, which show how the brain uses sugar for energy. The AI compares a patient’s scan to a large database of scans from people with confirmed types of dementia.

    It looks for patterns in brain activity linked to different types of dementia. For example:

    • Alzheimer’s disease affects memory and thinking
    • Lewy body dementia involves movement and attention
    • Frontotemporal dementia affects language and behaviour

    The AI can recognise patterns for nine different types of dementia, the researchers said.

    StateViewer also creates colour-coded brain maps, making it easier for doctors to understand what the AI is seeing and why it gave a particular diagnosis.

    “Behind every brain scan is a real person with a lot of questions,” said Leland Barnard, the lead researcher. “This tool gives doctors fast and accurate information that can help patients get the right care sooner.”

    What’s next

    The team now plans to test StateViewer in different hospitals and clinics to see how well it works in real-life situations.

    If successful, it could become a useful tool for doctors treating people with memory problems or suspected dementia.

    Experts say this is a step toward more precise, early diagnosis, which is important because treatment often works best when started early.

    “This is just the beginning,” Dr. Jones said. “Tools like this could help change the way we care for people with dementia.”

    Continue Reading

  • Skakkebæk NE, Lindahl-Jacobsen R, Levine H, Andersson AM, Jørgensen N, Main KM, Lidegaard Ø, Priskorn L, Holmboe SA, Bräuner EV, et al. Environmental factors in declining human fertility. Nat Reviews Endocrinol. 2022;18(3):139–57.

    Article 

    Google Scholar 

  • You YA, Park S, Kwon E, Kim YA, Hur YM, Lee GI, Kim SM, Song JM, Kim MS, Kim YJ et al. Maternal PM2.5 exposure is associated with preterm birth and gestational diabetes mellitus, and mitochondrial OXPHOS dysfunction in cord blood. Environmental science and pollution research international 2024.

  • Thurston GD. Moving beyond PM2.5 mass to more effectively protect health. Am J Respir Crit Care Med 2023.

  • Kohlhepp LM, Hollerich G, Vo L, Hofmann-Kiefer K, Rehm M, Louwen F, Zacharowski K, Weber CF. [Physiological changes during pregnancy]. Anaesthesist. 2018;67(5):383–96.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Kapraun DF, Wambaugh JF, Setzer RW, Judson RS. Empirical models for anatomical and physiological changes in a human mother and fetus during pregnancy and gestation. PLoS ONE. 2019;14(5):e0215906.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Zhao L, Li T, Wang H, Fan YM, Xiao Y, Wang X, Wang S, Sun P, Wang P, Jiangcuo Z et al. Association of co-exposure to metal(loid)s during pregnancy with birth outcomes in the Tibetan plateau. Chemosphere 2023:140144.

  • Pan SC, Huang CC, Chen BY, Chin WS, Guo YL. Risk of type 2 diabetes after diagnosed gestational diabetes is enhanced by exposure to PM2.5. Int J Epidemiol 2023.

  • Coogan PF, White LF, Yu J, Burnett RT, Seto E, Brook RD, Palmer JR, Rosenberg L, Jerrett M. PM2.5 and diabetes and hypertension incidence in the black women’s health study. Epidemiol (Cambridge Mass). 2016;27(2):202–10.

    Google Scholar 

  • Koo EJ, Bae JG, Kim EJ, Cho YH. Correlation between exposure to fine particulate matter (PM2.5) during pregnancy and congenital anomalies: its surgical perspectives. J Korean Med Sci. 2021;36(38):e236.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Dai XC, Liang DT, Sun F. [PM2.5 exposure-caused damage to male reproductive function: progress in research]. Zhonghua Nan Ke Xue. 2021;27(4):361–5.

    PubMed 

    Google Scholar 

  • Zhou S, Xi Y, Chen Y, Zhang Z, Wu C, Yan W, Luo A, Wu T, Zhang J, Wu M, et al. Ovarian dysfunction induced by chronic Whole-Body PM2.5 exposure. Small. 2020;16(33):e2000845.

    Article 
    PubMed 

    Google Scholar 

  • Trusz A, Ghazal H, Piekarska K. Seasonal variability of chemical composition and mutagenic effect of organic PM2.5 pollutants collected in the urban area of Wrocław (Poland). Sci Total Environ. 2020;733:138911.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Han L, Zhou W, Pickett ST, Li W, Qian Y. Multicontaminant air pollution in Chinese cities. Bull World Health Organ. 2018;96(4):233–e242.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Magee LA, Sharma S, Nathan HL, Adetoro OO, Bellad MB, Goudar S, Macuacua SE, Mallapur A, Qureshi R, Sevene E, et al. The incidence of pregnancy hypertension in India, Pakistan, Mozambique, and Nigeria: A prospective population-level analysis. PLoS Med. 2019;16(4):e1002783.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Grover S, Brandt JS, Reddy UM, Ananth CV. Chronic hypertension, perinatal mortality and the impact of preterm delivery: a population-based study. BJOG. 2022;129(4):572–9.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Sciatti E, Orabona R. Cardiovascular prevention after hypertensive disorders of pregnancy: do not forget fetal growth restriction! J Am Coll Cardiol. 2021;78(1):91.

    Article 
    PubMed 

    Google Scholar 

  • Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, Hughes BL, Bell J, Aagaard K, Edwards RK, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386(19):1781–92.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Çintesun E, Incesu Çintesun FN, Ezveci H, Akyürek F, Çelik Ç. Systemic inflammatory response markers in preeclampsia. J Lab Physicians. 2018;10(3):316–9.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Friedman C, Dabelea D, Thomas DSK, Peel JL, Adgate JL, Magzamen S, Martenies SE, Allshouse WB, Starling AP. Exposure to ambient air pollution during pregnancy and inflammatory biomarkers in maternal and umbilical cord blood: the healthy start study. Environ Res. 2021;197:111165.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar 

  • Yin J, Xia W, Li Y, Guo C, Zhang Y, Huang S, Jia Z, Zhang A. COX-2 mediates PM2.5-induced apoptosis and inflammation in vascular endothelial cells. Am J Translational Res. 2017;9(9):3967–76.

    CAS 

    Google Scholar 

  • Chen CC, Wang YR, Liu JS, Chang HY, Guo YL, Chen PC. Burden of cardiovascular disease attributable to long-term exposure to ambient PM2.5 concentration and the cost-benefit analysis for the optimal control level. Sci Total Environ 2023:164767.

  • Fujitani Y, Furuyama A, Hayashi M, Hagino H, Kajino M. Assessing oxidative stress induction ability and oxidative potential of PM(2.5) in cities in Eastern and Western Japan. Chemosphere. 2023;324:138308.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Aguilera J, Konvinse K, Lee A, Maecker H, Prunicki M, Mahalingaiah S, Sampath V, Utz PJ, Yang E, Nadeau KC. Air pollution and pregnancy. Semin Perinatol 2023:151838.

  • Chen H, Chen X, Hong X, Liu C, Huang H, Wang Q, Chen S, Chen H, Yang K, Sun Q. Maternal exposure to ambient PM(2.5) exaggerates fetal cardiovascular maldevelopment induced by homocysteine in rats. Environ Toxicol. 2017;32(3):877–89.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Agrawal A, Wenger NK. Hypertension during pregnancy. Curr Hypertens Rep. 2020;22(9):64.

    Article 
    PubMed 

    Google Scholar 

  • La Verde M, Luciano M, Fordellone M, Sampogna G, Lettieri D, Palma M, Torella D, Marrapodi MM, Di Vincenzo M, Torella M. Postpartum depression and inflammatory biomarkers of Neutrophil-Lymphocyte ratio, Platelet-Lymphocyte ratio, and Monocyte-Lymphocyte ratio: A prospective observational study. Gynecol Obstet Invest. 2024;89(2):140–9.

    Article 
    PubMed 

    Google Scholar 

  • Madendag Y, Madendag IC, Sahin E, Aydin E, Sahin ME, Acmaz G. How well do the popular ultrasonic techniques estimate amniotic fluid volume and diagnose oligohydramnios, in fact?? Ultrasound Q. 2019;35(1):35–8.

    Article 
    PubMed 

    Google Scholar 

  • Campbell AG, Miranda PY. Breastfeeding trends among very low birth weight, low birth weight, and normal birth weight infants. J Pediatr. 2018;200:71–8.

    Article 
    PubMed 

    Google Scholar 

  • Kim M, Okunowo O, Ades AM, Fuller S, Rintoul NE, Naim MY. Single-Center comparison of outcomes following cardiac surgery in low birth weight and standard birth weight neonates. J Pediatr. 2021;238:161–e167161.

    Article 
    PubMed 

    Google Scholar 

  • Edmond K. Introduction to Evidence for Global Health Care Interventions for Preterm or Low Birth Weight Infants. Pediatrics 2022, 150(Suppl 1).

  • Rumbajan JM, Yamaguchi Y, Nakabayashi K, Higashimoto K, Yatsuki H, Nishioka K, Matsuoka K, Aoki S, Toda S, Takeda S, et al. The HUS1B promoter is hypomethylated in the placentas of low-birth-weight infants. Gene. 2016;583(2):141–6.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • Nkwabong E, Kamgnia Nounemi N, Sando Z, Mbu RE, Mbede J. Risk factors and placental histopathological findings of term born low birth weight neonates. Placenta. 2015;36(2):138–41.

    Article 
    CAS 
    PubMed 

    Google Scholar 

  • O’Sharkey K, Xu Y, Cabison J, Rosales M, Yang T, Chavez T, Johnson M, Lerner D, Lurvey N, Corral CMT et al. Effects of In-Utero Personal Exposure to PM2.5 Sources and Components on Birthweight. Research square 2023.

  • Hao Y, Strosnider H, Balluz L, Qualters JR. Geographic variation in the association between ambient fine particulate matter (PM2.5) and term low birth weight in the united States. Environ Health Perspect. 2016;124(2):250–5.

    Article 
    PubMed 

    Google Scholar 

  • Sun X, Luo X, Zhao C, Zhang B, Tao J, Yang Z, Ma W, Liu T. The associations between birth weight and exposure to fine particulate matter (PM2.5) and its chemical constituents during pregnancy: A meta-analysis. Environ Pollution (Barking Essex: 1987). 2016;211:38–47.

    Article 
    CAS 

    Google Scholar 

  • Larrañaga I, Santa-Marina L, Molinuevo A, Álvarez-Pedrerol M, Fernández-Somoano A, Jimenez-Zabala A, Rebagliato M, Rodríguez-Bernal CL, Tardón A, Vrijheid M, et al. Poor mothers, unhealthy children: the transmission of health inequalities in the INMA study, Spain. Eur J Pub Health. 2019;29(3):568–74.

    Article 

    Google Scholar 

Continue Reading

  • Turkey shuts livestock markets to control foot and mouth disease

    Turkey shuts livestock markets to control foot and mouth disease

    File photo. [AP]

    Turkey said on Wednesday it will shut down all livestock marketplaces to control the spread of highly contagious foot and mouth disease.

    The Agriculture Ministry said it detected a new serotype of the disease that heightened the outbreak, due to animal movement after the Muslim religious holiday of Eid al Adha, which is typically marked by slaughtering livestock.

    The decision was taken to prevent further spread as teams continue to vaccinate animals against the disease, the ministry said. It will gradually lift the restrictions once the entire livestock population is vaccinated.

    The ministry also said the temporary closure will not disrupt supply and demand for meat and dairy products in Turkey.  [Reuters]


    Continue Reading

  • Which Medications Increase Microscopic Colitis Risk?

    Which Medications Increase Microscopic Colitis Risk?

    TOPLINE:

    Earlier reports blamed several medications including nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs), selective serotonin reuptake inhibitors (SSRIs), statins, and antihypertensive agents for triggering microscopic colitis. However, a Swedish study of adults aged 65 years or older found that most of these drugs didn’t increase the risk.

    METHODOLOGY:

    • Although medications are viewed as the main modifiable risk factors for microscopic colitis, research has been limited by nonpopulation-based samples, small and selective cohorts, and study designs vulnerable to immortal time, surveillance, and other biases.
    • Researchers analyzed prescription records, hospitalizations, medical diagnoses, and gut biopsy findings of more than 2.8 million Swedish individuals aged 65 years or older to determine whether any of the previously implicated medications increased the risk for microscopic colitis.
    • Target trials — one for each medication — were emulated by including only those without a history of inflammatory bowel disease or microscopic colitis, at least one healthcare encounter in the previous year, no use of a drug from the same class in the prior 180 days, and no known contraindications; the effect of initiating each medication with either not starting it or selecting an alternative therapy was compared.
    • The primary outcome was biopsy-verified microscopic colitis, with researchers estimating 12- and 24-month cumulative incidences for the risk for microscopic colitis.

    TAKEAWAY:

    • Both 12- and 24-month cumulative incidences for the risk for microscopic colitis were < 0.5% under all treatment strategies.
    • Estimated risk differences at 12 months and 24 months were close to null for the initiation of antihypertensive medications vs calcium channel blockers, initiation of NSAIDs vs noninitiation, initiation of PPIs vs noninitiation, and initiation of statins vs noninitiation.
    • However, the initiation of SSRIs vs mirtazapine showed an estimated 12-month risk difference of 0.04% (95% CI, 0.03-0.05); similar results were observed for the estimated 24-month risk difference.
    • The use of NSAIDs, PPIs, and SSRIs was tied to more colonoscopy exams with normal biopsy results, suggesting that the apparent rise in microscopic colitis after starting an SSRI may have reflected unmeasured bias from ongoing differences in medical care.

    IN PRACTICE:

    “Our study demonstrated that, contrary to the previous belief, it’s unlikely that medications are the primary triggers for microscopic colitis,” the lead author commented in a press release. “Clinicians should carefully balance the intended benefits of these medication classes against the very low likelihood of a causal relationship with MC [microscopic colitis],” the authors concluded.

    SOURCE:

    This study was led by Hamed Khalili, MD, MPH, Gastroenterology Unit, Department of Medicine, Massachusetts General Hospital in Boston. It was published online in the Annals of Internal Medicine.

    LIMITATIONS:

    The Swedish registries do not capture primary care visits, so any symptoms or diagnoses recorded there that might have prompted a colonoscopy went unmeasured. Incomplete colonoscopy records may have obscured why participants actually underwent the procedure. Furthermore, the absence of data on smoking status, body weight, laboratory results, and contraindications could have biased the findings.

    DISCLOSURES:

    This study was funded in part by the National Institutes of Health, the Swedish Research Council, and the Eric and Wendy Schmidt Center at the Broad Institute of MIT and Harvard. Some authors declared receiving consulting fees, serving on advisory boards, receiving financial support, and other ties with certain pharmaceutical companies.

    This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

    Continue Reading

  • Emotional Response to Music May Enhance Memory Specificity

    Emotional Response to Music May Enhance Memory Specificity

    Music that evokes an emotional response may influence the specificity of memory recall, new research suggests.

    Investigators found that participants who were shown a series of images of everyday items before listening to music were more likely to remember only general details of the photos if they experienced a more emotional response to the music, while those who had a moderate emotional response were more likely to recall specific details.

    Stephanie L. Leal, PhD

    “Most people think that emotional things are better remembered, but they actually aren’t. It’s just parts of the memory that are affected, not the whole memory,” co-investigator Stephanie L. Leal, PhD, assistant professor in the Department of Integrative Biology & Physiology at the University of California Los Angeles (UCLA), told Medscape Medical News. “One size doesn’t fit all when it comes to music and memory.”

    Interestingly, familiarity with a song was not associated with either general or detailed memory.

    “We played the same songs for everybody, but importantly, everyone responded differently. So I think personalization and taking individual preferences into account is going to be important for interventions,” said Leal, who is also director of the Neuroscience of Memory, Mood, and Aging Laboratory at UCLA.

    The findings were published online on July 23 in The Journal of Neuroscience.

    Memory Complexities

    As previously reported by Medscape Medical News, previous research has shown that both music appreciation and participations are tied to improvement in executive function and memory.

    For this study, researchers wanted to dive into the complexities of memory, including the possible connection between music and differing aspects of memory.

    “We tend to remember more of the gist of something emotional that happened and not as much of the details. So we wanted to see if music could boost certain parts of memory but not all of the parts,” she said.

    Many previous music studies have included older individuals, especially those with dementia. For this project, investigators chose instead to assess a younger population because they wanted to use their data as a “baseline” before moving on to further research in groups that are older and/or have impaired conditions such as depression or Alzheimer’s disease, Leal said.

    “We wanted to see what happens in healthy people first and then apply it to other populations,” she said.

    The study included 130 healthy undergraduate students between the ages of 18 and 35 years from Rice University, Houston.

    During the initial phase of memory formation — called the “encoding” phase — each participant was shown 128 images of common household objects and asked to choose whether the object should be considered as an indoor or outdoor item.

    Participants then donned headphones and listened to 10 minutes of classical music pieces, ambient soundscapes, or silence while they filled out questionnaires about their medical history.

    After the music ended, participants spent about 20 minutes filling out additional questionnaires, including a rating of the music or sounds they heard on the basis of emotional arousal, positive or negative reaction, or familiarity.

    They then viewed a set of 192 images that included some they hadn’t seen before (foils) and others that were identical (targets) or similar (lures) to the photos viewed earlier. Participants were asked to classify an image as old or new, allowing the researchers to measure target recognition — a measure of general memory — or lure discrimination — a measure of detailed memory.

    Big-Picture Recall

    General recall of the images was greater among those who experienced either low or high emotional response to music than among those who experienced moderate changes in emotional arousal (P for both < .001).

    More detailed memories were reported by those who reported only a moderate emotional response to music than those who reported a low or high emotional response (P for both < .001).

    There were no significant associations between memory of the images and song familiarity or whether a song was happy or sad.

    “Overall, music modulated both general and detailed memory, but individual differences in emotional response were crucial — participants listened to the same music yet responded differently,” the investigators wrote.

    “These findings suggest that music interventions may not uniformly enhance memory, emphasizing the need for personalized approaches in treating memory and mood impairments,” they added.

    The research suggests that a high emotional response may cloud details more than a moderate response.

    “Yes, the idea is that if something is very emotionally arousing, maybe we don’t want to remember the details associated with it. Maybe we just want to remember that general feeling or the bigger impact of that event, whether it’s positive or negative,” Leal said. “Maybe we just want to take the ‘big picture’ from that.”

    Early Days

    Commenting on the findings for Medscape Medical News, Daniel L. Bowling, PhD, assistant professor in the Department of Psychiatry and Behavioral Sciences at the Stanford School of Medicine, Palo Alto, California, noted that the study “follows the general trend” of research that breaks down large concepts, such as memory, into specific features.

    photo of  Daniel Bowling
    Daniel L. Bowling, PhD

    Bowling, who is also director of the Music and Brain Health Lab at Stanford, was not involved with the current study.

    “This showed different levels of responses to music that were differentially related to varying types of memory that you might want to target,” Bowling said.

    For example, if a clinician’s purpose is cognitive training, with more of an emphasis on details, “you might want more moderate levels of [emotional] arousal. But if you want more big-picture stuff, which could be critical when asking people about their life, then higher levels of arousal may be better,” he added.

    He noted that because the researchers used almost a “pretreatment,” with music used before the recall task, it would be interesting to know if using such a pretreatment before taking a test could possibly improve performance.

    There are interventions, some of which Bowling is involved with, that are looking at supporting arousal and attention during studying. 

    A controlled study comparing these things and looking systematically into effects on different types of memory would be helpful, “but we’re really at the beginning of figuring all of this stuff out,” he said.

    Although the current study has some limitations and needs to be replicated, “any kind of talk toward systematic effects of different musical parameters or emotional modeling starts to help us bring this into the scientific-medical realm. And that’s a real strength here,” Bowling concluded.

    The investigators reported having no relevant financial relationships. Bowling reported consulting for and owning stock in Spiritune, an app that develops playlists for different purposes, including improved workflow.

    Continue Reading

  • Pakistan records 14th polio case so far in 2025

    ISLAMABAD, July 2 (Xinhua) — As Pakistan continued to battle a crippling disease, the country recorded another polio case, increasing the overall tally to 14 so far in 2025, the Health Ministry said.

    The new case was reported from the northwest North Waziristan district of Khyber Pakhtunkhwa province as health officials confirmed the detection of type 1 wild poliovirus in a 19-month-old girl.

    So far, eight cases have been reported from the province, four from the southern Sindh province and one from the eastern Punjab province and the northern Gilgit-Baltistan region each.

    Special polio vaccination campaigns will soon kick off in 11 union councils of North Waziristan district, health officials said. Enditem

    Continue Reading

  • Parasite-Specific Organelle Proteins as Antimalarial Targets

    Parasite-Specific Organelle Proteins as Antimalarial Targets


    Register for free to listen to this article

    Thank you. Listen to this article using the player above.


    Want to listen to this article for FREE?


    Complete the form below to unlock access to ALL audio articles.

    University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the parasite responsible for the deadliest form of human malaria, that could make novel, highly targeted anti-malarial therapies possible.

    Led by Karine Le Roch, a professor of molecular, cell and systems biology, the team identified two key proteins inside the “apicoplast” — a unique, parasite-specific organelle found in P. falciparum — that control gene expression. These proteins belong to the RAP (RNA-binding domain Abundant in Apicomplexans) family of proteins. Far more numerous in parasites than in humans, RAP proteins play critical roles in regulating RNA molecules and translating them into proteins inside parasite organelles.

    Using advanced genetic tools, the team created knockdown strains of P. falciparum to selectively deactivate the two RAP proteins, PfRAP03 and PfRAP08. The team found the loss of either protein led to parasite death, confirming their essential roles.

    The researchers also discovered that PfRAP03 and PfRAP08 specifically bind to ribosomal RNA (rRNA) and transfer RNA (tRNA) molecules, respectively. These non-coding RNAs are fundamental to protein synthesis within the apicoplast.

    “This is the first time anyone has shown how RAP proteins in the apicoplast directly interact with rRNA and tRNA,” said Le Roch, who directs the UCR Center for Infectious Disease Vector Research. “We’ve now shown mechanistically how these proteins regulate translation in an organelle that’s completely foreign to the human body.”

    Le Roch explained that humans have six RAP proteins, but parasites like Plasmodium have more than 20.

    “This evolutionary expansion suggests that RAP proteins may perform parasite-specific functions, making them exciting drug targets,” she said.

    The study, published in Cell Reports, builds on the team’s previous research on RAP proteins in parasite mitochondria and represents the first detailed mechanistic analysis of their function in the apicoplast.

    Unlike any structure found in human cells, the apicoplast is unique to apicomplexan parasites — a large group of single-celled organisms that includes PlasmodiumToxoplasma gondii, and Babesia. This uniqueness makes it an ideal target for therapies that can eliminate the parasite without harming the human host.

    “While the focus of our paper is malaria, the implications extend to other apicomplexan diseases like toxoplasmosis — dangerous especially to pregnant women — and babesiosis, a growing tick-borne threat in the United States,” Le Roch said. “This work exposes vulnerabilities across an entire class of parasites, revealing the molecular machinery these parasites rely on. If we can take it apart, we can stop these diseases before they take hold.”

    Though no drugs currently target RAP proteins, Le Roch’s lab is working toward solving the 3D structure of these RNA-protein complexes, a crucial step toward structure-guided drug design.

    “Our research is a step toward future therapeutic strategies,” Le Roch said. “By targeting essential, parasite-specific proteins that have no human counterparts, we can develop drugs that are both effective and have minimal side effects.”

    Reference: Hollin T, Chahine Z, Abel S, et al. RAP proteins regulate apicoplast noncoding RNA processing in Plasmodium falciparum. Cell Rep. 2025;44(7):115928. doi: 10.1016/j.celrep.2025.115928

    This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.

    Continue Reading